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Arachidonic acid (AA) stimulates cell adhesion through a p38 mitogen activated protein kinase-
mediated RhoA signaling pathway. Here we report that a proteomic screen following AA-treatment
identiﬁed nucleolin, a multifunctional nucleolar protein, in a complex with the GTPase, RhoA, that
also included the Rho kinase, ROCK. AA-stimulated cell adhesion was inhibited by expression of
nucleolin-targeted shRNA and formation of the multiprotein complex was blocked by expression
of dominant-negative RhoA. AA-treatment also induced ROCK-dependent serine phosphorylation
of nucleolin and translocation of nucleolin from the nucleus to the cytoplasm, where it appeared
to co-localize with RhoA. These data suggest the existence of a new signaling pathway through
which the location and post-translational state of nucleolin are modulated.
Structured summary:
Nucleolin physically interacts with RHOA by anti bait coimmunoprecipitation (View Interaction 1, 2)
Nucleolin and RHOA colocalize by ﬂuorescence microscopy (View interaction)
ROCK physically interacts with RHOA by pull down (View interaction)
ROCK physically interacts with HSP 90-beta, HSP70, Nucleolin, Nebulin and RHOA by pull down (View
interaction)
Nucleolin physically interacts with ROCK2 by anti bait coimmunoprecipitation (View interaction)
ROCK physically interacts with Nucleolin and RHOA by pull down (View interaction)
 2011 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction ucts have been implicated in a variety of diseases, including cancerCell adhesion to the extracellular matrix is a critical feature of
many cellular processes, including development, wound healing,
and cancer cell metastasis. This adhesion depends on signaling
pathways that modulate integrin activity [1]; thus, understanding
these pathways and the environmental factors that modulate them
allows for a rational approach to the development of therapies tar-
geting cell adhesion [2]. One important class of environmental
molecules is the eicosanoids. Arachidonic acid (AA) is a dietary
n-6 polyunsaturated fatty acid that can be generated either by
phospholipase-mediated release from cell membranes [3] or as a
metabolite of linoleic acid, a fatty acid present at high levels in
most Western diets [4]. These fatty acids and their bioactive prod-on behalf of the Federation of Euro
tathione S-transferase-linked
m
2-05, National Institute of
Research Triangle Park, NC
ts).[5]. Previously, we observed that AA-stimulated adhesion of MDA-
MB-435 human cancer cells to extracellular matrix molecules [6]
in a manner that depended on several signaling pathways [7–10].
One of these pathways involves RhoA, a small GTPase, the regula-
tion of which has been implicated in tumor metastasis [11]. In this
paper, we report the results of a proteomic search for factors asso-
ciated with RhoA in fatty acid-stimulated cell adhesion.
2. Materials and methods
2.1. Reagents and cell culture
AA (Cayman Biochemicals) was used as described [6]. Collagen
type IV and poly-D-lysine were from BD Biosciences. Primary anti-
bodies used were anti-Rho (from either Cytoskeleton Inc. or Santa
Cruz Biotechnology), anti-HA (Upstate), anti-GAPDH (Upstate),
anti-phosphotyrosine (Upstate), anti-phosphoserine (Pharmingen),
anti-nucleolin (either Stressgen or Santa Cruz), and anti-ROCKII
(Santa Cruz).pean Biochemical Societies.
Fig. 1. Proteins associated with Rho-GTP identiﬁed by mass spectrometry. GST-RBD
was used to pull down Rho-GTP from cell lysates that were untreated or treated
with arachidonic acid for 5 min. Proteins separated by SDS–PAGE were cut out and
identiﬁed by mass spectrometry as: nucleolin (arrow), HSP70 (), HSP90b (+) and
nebulin (>). The data shown are representative of two experiments.
Fig. 2. Nucleolin forms a complex with Rho. (A) GST-RBD was used to pull down
active Rho in cell lysates that were treated with arachidonic acid. The precipitates,
and whole cell lysates used in the pull-down assay, were separated by SDS–PAGE
and immunoblotted for nucleolin, Rho A and GAPDH. The data shown are
representative of four experiments. (B) Whole cell lysates were prepared from
cells exposed to arachidonic acid (AA) (30 lM) or vehicle (V) (ethanol/NaCl/KOH)
for 20 min. Nucleolin was immunoprecipitated from the lysates and analyzed by
immunoblotting for RhoA and nucleolin. (C) Nucleolin was immunoprecipitated
from whole cell lysates as above and analyzed by immunoblotting for ROCK and
nucleolin.
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linked Rho binding domain of ROCK (GST-RBD) was a gift from
John P. O’Bryan (University of Illinois). 3 HA-tagged wild-type
RhoA, dominant-negative RhoA (T19N), and constitutively active
RhoA (G12V) were from the University of Missouri-Rolla cDNA Re-
source Center (www.cdna.org). Sequences of a short hairpin RNA
targeting nucleolin and a scrambled negative control are AAGAA-
GACAGTTACACCAGCC and AATCAACAGAGAAGCCTAGC, respec-
tively. Expression cassettes containing the U6 RNA polymerase
promoter sequence and terminator sequence were generated using
the Silencer Express kit (Ambion) and subcloned into the pSEC™
hygro vector (Ambion).
The human mammary adenocarcinoma cell line MDA-MB-435
was obtained from Dr. Janet Price (M.D. Anderson Cancer Center)
and cultured as described [6]. Cell transfections were performed
using FuGENE 6 (Roche Applied Science). Medium was changed
24 h after transfection to minimal essential medium (MEM) con-
taining 200 lg/ml of hygromycin; stable populations were har-
vested and grown in hygromycin-containing medium.
2.2. Adhesion and small G protein activation assays
Adhesion assays were carried out essentially as described [6].
When appropriate, cells were treated with ROCK inhibitors
Y27632 or H1152 (Calbiochem) for 30 min. For G protein activa-
tion, cells were harvested, washed and allowed to recover in ser-
um-free MEM for 30 min. After treatment with 30 lM AA, cells
were washed with ice-cold phosphate buffered saline (PBS) and
lysed with 50 mM HEPES, pH 7.5, 1.5 mM MgCl2, 150 mM NaCl,
10% glycerol, 1% Triton X-100, 0.25% sodium deoxycholate, 1 mM
EGTA, 100 mM NaF, 10 lg/ml of each aprotinin and leupeptin,
and 1 mM Na3VO4. Lysates were clariﬁed and incubated for 1 h
with GST-RBD bound to glutathione–Sepharose beads (Amer-
sham). Samples were washed with lysis buffer and bound proteins
were eluted by boiling in LDS NuPage sample buffer (Invitrogen),
separated by electrophoresis on a 4–12% Bis–Tris NuPage gel and
immunoblotted with appropriate antibodies.
2.3. Immunoprecipitations
Cells were transfected overnight with a 3 HA-tagged wild type
Rho DNA construct, harvested, washed, allowed to recover in ser-
um-free MEM for 30 min, and treated with 30 lM AA, prior to
being lysed with 50 mM Tris–HCl, pH 7.4, 1% NP-40, 0.25% sodium
deoxycholate, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF, 1 mM
Na3VO4, 1 mM NaF, 10 lg/ml aprotinin, and 10 lg/ml leupeptin).
Lysates were clariﬁed by centrifugation, then precleared for 1 h
with protein G agarose beads (Santa Cruz) and normal mouse ser-
um, followed by incubation for 1 h with primary antibody bound to
protein G beads. Precipitates were washed with lysis buffer and
analyzed by SDS–PAGE and immunoblotting.
2.4. Mass spectrometry and confocal microscopy
Active RhoA was generated by treating MDA-MB-235 cells with
30 lM AA for 20 min as described [10]. GTP-bound RhoA was then
pulled down and analyzed by SDS–polyacrylamide gel electropho-
resis. In-gel digestion and mass spectrometry were performed
essentially as described [12].
For confocal microscopy, cells were cultured overnight at
2  104 cells/collagen IV-coated glass coverslip. After treatment,
cells were washed with PBS, ﬁxed in 4% paraformaldehyde for
45 min, permeabilized with 0.3% Triton X-100 in PBS for 10 min
and incubated for 45 min in 4% donkey serum in 0.1% gelatin block-
ing solution. Primary antibodies against nucleolin (diluted 1:500)
and Rho (diluted 1:200) were added for 45 min, then cells wereblocked overnight at 4 C, and secondary antibodies [Alexa Fluor
488 donkey anti-rabbit and Alexa Fluor 594 donkey anti-mouse
secondary antibodies (Invitrogen), diluted 1:2000], were added
for 45 min. Slides were mounted using Prolong Gold anti-fade with
DAPI (Invitrogen).
3. Results and discussion
3.1. Nucleolin is found in a complex with Rho and ROCK
We set out to identify proteins that associate with active Rho
after AA stimulation. MDA-MB-435 human tumor cells were
620 M.C. Garcia et al. / FEBS Letters 585 (2011) 618–622treated with 30 lM AA and active RhoA was immunoprecipitated
as described (Section 2). Proteins in the immunoprecipitates were
separated by electrophoresis and identiﬁed by mass spectrometry.
Among the proteins identiﬁed, a 90 kDa species was observed in
the AA-treated lysates that was not present in the untreated ly-
sates (Fig. 1). This band, upon digestion and analysis by MALDI-
TOF mass spectrometry, yielded 23 unique peptides, corresponding
to 36% sequence coverage, identifying it as nucleolin, a nucleolar
phosphoprotein that functions in nucleogenesis [13,14]. The data
yielded a Mowse-based MASCOT score of 135 with a GPS assigned
conﬁdence index of 100% (Supplementary Table 1). We validated
the mass spectrometry results by performing Rho pull-down as-
says and identifying nucleolin in the precipitate by electrophoresis
and immunoblotting with nucleolin-speciﬁc antibody (Fig. 2A). We
then reversed the experiment, testing for and observing an in-
crease in RhoA in immunoprecipitates of nucleolin speciﬁcally
after fatty acid treatment of these cells (Fig. 2B).
Rho-associated kinase (ROCK) is frequently found associated
with Rho-GTP [15,16]; thus, we tested for its presence in the
complex by immunoprecipitating nucleolin from AA-treated and
untreated lysates and observed an increase in co-immunoprecipita-
tion of ROCK with nucleolin in lysates of AA-treated cells (Fig. 2C),
suggesting a novel multiprotein signaling complex that includes
Rho, ROCK and nucleolin.Fig. 3. Nucleolin is critical for arachidonic acid-induced adhesion on type IV
collagen. (A) Cell lysates from MDA-MB-435 cells (M), cells with stable expression
of the scrambled shRNA (S), and two cell lines with stable expression of the shRNA
targeting nucleolin (K1 and K2) were separated by SDS–PAGE and immunoblotted
for nucleolin and GAPDH. (B) Cell adhesion to collagen IV was assayed in the cells
lines listed above, treating with vehicle (h) or 30 lM arachidonic acid (AA) (j).
Values were compared to non-transfected cells (P). Statistically signiﬁcantly
differences between transfected and non-transfected, vehicle-treated cells [as
determined by Student’s t-test (P < 0.05)] are indicated (). The data shown are
representative of three experiments. (C) GST-RBD was used to pull down active Rho
from cell lysates from cells listed above that were treated with arachidonic acid.
Precipitating proteins and whole cell lysates were analyzed by SDS–PAGE and
immunoblotted for nucleolin, RhoA, and GAPDH. The data shown are representative
of two experiments.3.2. Nucleolin is critical for AA-induced adhesion on type IV collagen
AA has been previously shown to alter a variety of signaling
pathways that are important for cell adhesion [7–10]. Furthermore,
AA-treated MDA-MB-435 cells that adhere to collagen type IV
show signiﬁcant changes in cytoskeletal structures, includingFig. 4. Rho signaling is critical for complex formation. (A) MDA-MB-435 cells were
transfected with HA-tagged wild type (RhoA) or constitutively active (RhoAG12V)
RhoA for 24 h. Nucleolin was precipitated from arachidonic acid-treated (AA) and
vehicle-treated (V) lysates. The precipitates were analyzed by SDS–PAGE and
immunoblotted for the HA-tag and nucleolin. Quantiﬁcation was performed using
ImageJ and expressed as a ratio vs. wild-type transfected, vehicle-treated cells and
normalized to the amount of precipitated nucleolin. Whole cell lysates used in the
immunoprecipitation were separated by SDS–PAGE and immunoblotted for the HA-
tag and GAPDH. (B) Nucleolin was immunoprecipitated from cell lysates of HA-
tagged wild-type (RhoA) or dominant negative (RhoAT19N) RhoA expressing cells
treated with vehicle (V) or arachidonic acid (AA). The precipitates were immuno-
blotted for the HA-tag and nucleolin. Whole cell lysates were separated by SDS–
PAGE and immunoblotted for the HA-tag and GAPDH. The data shown are
representative of three experiments. ROCK was also found to be present by
immunoblotting in whole cell lysates used in both panels A and B (data not shown).
Fig. 5. Arachidonic acid stimulates ROCK-dependent serine phosphorylation of
nucleolin. (A) Lysates from vehicle-treated (V) and arachidonic acid-treated (AA)
cells were precipitated for nucleolin and immunoblotted for phosphoserine,
phosphotyrosine and nucleolin. (B) Nucleolin was immunoprecipitated from lysates
of cells treated with vehicle (V), arachidonic acid (AA), vehicle plus H1152 ROCK
inhibitor (I) and arachidonic acid plus H1152 (IAA). The precipitates were
immunoblotted for nucleolin and phosphoserine. Data are representative of three
individual experiments. Quantiﬁcations of phosphoserine bands were performed
using ImageJ, normalized to nucleolin and expressed as a ratio vs. the bands from
vehicle-treated cells.
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(unpublished data). RhoA activity is critical for this AA-induced cell
adhesion to type IV collagen [10]. To test whether nucleolin is
important for this process, we transfected MDA-MB-435 cells with
nucleolin-targeted shRNA and control shRNA vectors. Two popula-
tions of cells expressing the nucleolin-targeted shRNA exhibited a
signiﬁcant reduction of nucleolin protein (63% and 82%, respec-
tively) (Fig. 3A) and both populations were completely blocked in
AA-induced adhesion when compared to control shRNA-containing
cells (Fig. 3B). However, we observed that nucleolin protein reduc-
tion did not block the stimulation of RhoA activity by AA (Fig. 3C).
The simplest interpretation of this data is that nucleolin functions
downstream of RhoA activation. Other model systems have pro-
vided evidence for a role of nucleolin in adhesion [17–19], but
our data suggest a novel mechanism in which nucleolin is regu-
lated by a key signaling pathway.
3.3. Rho signaling is critical for complex formation
We next asked if RhoA signaling was critical for its association
with nucleolin. Cells were transfected with a wild-type HA-tagged
RhoA, a constitutively active HA-tagged RhoAG12V or a dominant
negative HA-tagged RhoAT19N. We observed an increase in the
association of both wild-type RhoA and constitutively active RhoA
with nucleolin in AA-treated cell lysates (Fig. 4A). In contrast, dom-
inant-negative RhoA did not associate with nucleolin, even in AA-Fig. 6. Arachidonic acid induces ROCK-dependent translocation of nucleolin from the nu
panels E–H: cells treated with arachidonic acid (AA); panels I–L: cells treated with v
arachidonic acid plus inhibitor (IAA). Adherent cells on collagen IV-coated cover slips wer
to identify cell nuclei. Co-localization of Rho and nucleolin is displayed in merged image
lower left corner of each panel D, H, L, and P (enclosed in the dotted lines). Images are
applied at a concentration of 10 lM, 30 min prior to addition of arachidonic acid or vehtreated cells, indicating that Rho activation is critical for the asso-
ciation with nucleolin (Fig. 4B). However, the constitutively active
RhoA did not show increased association with nucleolin in vehicle-
treated cells, indicating that RhoA activity alone is not sufﬁcient for
recruitment of nucleolin to the complex. Recently, nucleolin has
been identiﬁed as a binding partner to the small GTPase K-Ras4B
and a nuclear guanine nucleotide exchange factor, BIG [20,21]. It
has also been shown that this binding is independent of GTP bind-
ing to K-ras [22]. Our data complement these ﬁndings, and suggest
that (1) the interaction of Rho and nucleolin may be a general phe-
nomenon of importance to this signaling pathway, and (2) at least
in the MDA-MB-435 cells, other factors activated by exposure to
AA are critical for formation of this complex.
3.4. AA stimulates ROCK-dependent nucleolin serine phosphorylation
Phosphorylation of nucleolin has been linked to both its activity
and cellular localization [23]. We hypothesized that AA treatment,
which is known to activate multiple protein kinase pathways, may
stimulate nucleolin phosphorylation. To test this hypothesis, we
immunoprecipitated nucleolin from AA-treated and untreated
MDA-MB-435 cell lysates and observed that nucleolin immunopre-
cipitated from AA-treated cells was serine phosphorylated, but not
tyrosine phosphorylated (Fig. 5A). A ROCK inhibitor signiﬁcantly
decreased the AA-stimulated increase in serine phosphorylation
of nucleolin (Fig. 5B). We were unable to demonstrate direct phos-cleus into the cytoplasm. Panels A–D: MDA-MB-435 cells treated with vehicle (V);
ehicle plus Y27632, an inhibitor of ROCK (I); and panels M–P: cells treated with
e probed for nucleolin (red) and Rho (green) as described, and DAPI (blue) was used
s (panels D, H, L and P) as yellow. A section of each merged image is enlarged in the
representative of three separate experiments. When used, the ROCK inhibitor was
icle.
622 M.C. Garcia et al. / FEBS Letters 585 (2011) 618–622phorylation of nucleolin by ROCK in in vitro kinase assays (data not
shown), suggesting that nucleolin may be phosphorylated by a
downstream kinase whose activity depends on ROCK.
3.5. AA induces ROCK-dependent translocation of nucleolin from the
nucleus into the cytoplasm
Nucleolin has been shown to localize in multiple cell compart-
ments [23] and to appear on the cell surface, potentially facilitating
cell adhesion [19,24]. We used confocal microscopy to show that in
vehicle-treated MDA-MB-435 cells, nucleolin was located primar-
ily in the nucleus, with some in the cytoplasm (Fig. 6A and C),
whereas Rho was located only in the cytoplasm and did not co-
localize with nucleolin (Fig. 6B and D). In cells treated with AA,
the majority of nucleolin appeared in the cytoplasm, with a small
amount remaining in the nucleus (Fig. 6E). Rho localization did
not change with AA treatment and nucleolin appeared to co-local-
ize with Rho in the cytoplasm (Fig. 6F and H). [Several different
antibodies to nucleolin and RhoA were tested and each yielded
similar staining (data not shown), suggesting the translocation is
not due to an artifact of the particular antibody. Furthermore, the
staining for nucleolin disappeared when cells carrying the nucleo-
lin-speciﬁc shRNA were used, indicating the staining is speciﬁc for
nucleolin.] Treatment of the cells with Y27632, a ROCK inhibitor,
had no effect on the localization of Rho or nucleolin in cells not ex-
posed to AA (Fig. 6I–L). The ROCK inhibitor did successfully block
the translocation of nucleolin from the nucleus to the cytoplasm
in AA-treated cells (Fig. 6M–P), suggesting that ROCK activity is
critical for nucleolin translocation.
The mechanism by which nucleolin interacts with this complex
of signaling proteins is not yet clear. However, this work identiﬁes
nucleolin as a required cofactor in fatty acid-stimulated cell adhe-
sion and places its role downstream of Rho/ROCK, implicating
nucleolin, or its interacting partners, as attractive targets for inter-
vention in altering cell adhesion for therapeutic purposes.
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